• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体攻击阶段的冻融激活:I. 活性C56复合物形成过程中两个步骤的分离

Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.

作者信息

Dessauer A, Rother U, Rother K

出版信息

Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:75-81.

PMID:6587745
Abstract

The activation of the attack phase of C, C5-C9, is generally assumed to be dependent on the enzymes of the C activation pathways which cleave C5 into C5b and C5a. C5b will then form a complex with C6 that binds to membranes and, in the presence of C7-C9, effects cell lysis. In contrast, however, a variety of physicochemical means was found to activate C5 + C6 independently of the convertases and without apparent generation of the C5a peptide. By freezing and thawing of C5 + C6 a hemolytic C--56 activity was generated: (C--56 ).f The activation proceeded in two steps: (1) during a preincubation period of the two components the time and temperature dependent formation of an activatable intermediate was observed and (2) the intermediate C--56 could then be endowed with hemolytic activity by freezing and thawing. The intermediate as well as the activated (C--56)f complex was separated from C5 and C6 by anion exchange chromatography. While the isolated intermediate was labile, the active product after freezing and thawing was stable.

摘要

补体C5 - C9攻击阶段的激活通常被认为依赖于补体激活途径中的酶,这些酶将C5裂解为C5b和C5a。然后,C5b会与C6形成复合物,该复合物结合到细胞膜上,并在C7 - C9存在的情况下导致细胞裂解。然而,与之相反的是,人们发现多种物理化学方法可独立于转化酶激活C5 + C6,且不会明显产生C5a肽。通过对C5 + C6进行冻融,产生了溶血C56活性:(C56)f。激活过程分两步进行:(1) 在两种成分的预孵育期内,观察到了可激活中间体的时间和温度依赖性形成;(2) 然后通过冻融赋予中间体C56溶血活性。中间体以及激活后的(C56)f复合物通过阴离子交换色谱法与C5和C6分离。虽然分离出的中间体不稳定,但冻融后的活性产物是稳定的。

相似文献

1
Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.补体攻击阶段的冻融激活:I. 活性C56复合物形成过程中两个步骤的分离
Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:75-81.
2
Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.补体攻击阶段的冻融激活:II. 转化酶产生的C56与冻融产生的C56的比较。
Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:83-8.
3
Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.人补体系统第五和第六成分的激活:酸性条件下C6依赖性的C5裂解及双分子溶解复合物C5b,6a的形成
J Immunol. 1983 Aug;131(2):892-8.
4
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.细菌对补体介导杀伤作用的抗性机制研究。VI. IgG通过在C5裂解前的一个步骤发挥作用,提高C5b-9对大肠杆菌0111B4的杀菌效率。
J Immunol. 1983 Nov;131(5):2570-5.
5
Terminal complement components play a role in the expression of C5a.终末补体成分在C5a的表达中起作用。
J Immunol. 1987 Feb 1;138(3):838-41.
6
Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase.人白细胞弹性蛋白酶对补体第五成分的裂解及功能性活性C5b6样复合物的生成。
Immunobiology. 2000 Jan;201(3-4):470-7. doi: 10.1016/S0171-2985(00)80099-6.
7
Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.有证据表明C5b可识别并介导C8掺入补体溶细胞复合物。
J Immunol. 1987 Sep 15;139(6):1960-4.
8
The release of C5a in complement-activated serum does not require C6.补体激活血清中C5a的释放不需要C6。
J Immunol. 1989 Aug 15;143(4):1228-32.
9
Transmembrane channel-formation by five complement proteins.五种补体蛋白形成跨膜通道。
Biochem Soc Symp. 1985;50:235-46.
10
Relative inefficiency of terminal complement activation.末端补体激活的相对低效性。
J Immunol. 1988 Nov 1;141(9):3117-22.

引用本文的文献

1
Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system.蛋白类药物及其启示:在抑制补体系统的多蛋白级联反应时,要预料到意料之外的情况。
Immunol Rev. 2023 Jan;313(1):376-401. doi: 10.1111/imr.13164. Epub 2022 Nov 18.